West Palm Beach, Florida (PRWEB) December 11, 2012
The Project for Natural Health Choices Inc. recommends consuming 30 g of flaxseed daily as new research findings indicate that flaxseed may be able to dramatically reduce your risk of a stroke and heart attack. The research was conducted at the University Hospital Holguin and presented at the November 5, 2012 American Heart Association 2012 Scientific Sessions.
In the study there were 110 subjects who had been diagnosed with peripheral arterial disease. The majority of the participants were also diagnosed with hypertension and were on antihypertensive drugs.
They gave half the subjects 30g of flaxseed a day in different food sources and the other half ate diets with no flaxseed.
After six months, the researchers found that the flaxseed group had their blood pressure reduced an average of:
•10 mm Hg in their systolic pressure
•7 mm Hg in their diastolic levels
The research team calculated that these drops could translate into a reduction of about 50 percent in cases of stroke, and a 30 percent reduction in heart attack rates.
If interested in lowering risk of stroke or heart attack, consider adding flaxseed into a balanced diet. Flaxseed can be found in foods like flaxseed coated bagels, buns or muffins and can also simply be purchased and added to virtually any food.
This release has been sponsored by the Project for Natural Health Choices Inc., a natural health company that wants to help people improve their health through natural methods such as natural dietary supplements, exercise, and other natural therapies. To learn more about the Project for Natural Health Choices Inc. and “The Bill of American Health Rights" petition that fights to protect the constitutional right that people have to employ natural health practices which include the use of and access to natural health products, supplements, and therapies, go to http://www.naturalhealthchoicesproject.com/petition/.
Read the full story at http://www.prweb.com/releases/2012/12/prweb10183424.htm.
Copyright©2012 Vocus, Inc.
All rights reserved